ARA-290

ARA-290

ARA-290 (cibinetide) is a synthetic 11-amino-acid peptide derived from the helix-B domain of erythropoietin, studied as a research material. This listing is for laboratory research use only. It is not a drug, food, cosmetic, or dietary supplement, and it is not approved for human or veterinary use.

Research Context

ARA-290 appears in the scientific literature as a non-erythropoietic EPO-derived peptide examined at the innate repair receptor (EPOR–β-common / CD131) in nerve-injury and inflammatory models. This page does not describe administration, dosing, or personal use.

Research Overview

Published work has examined ARA-290 in controlled experimental systems of innate-repair-receptor signaling, without claiming erythropoietic activity. Findings from those models are not established as safe or effective for people or animals, and nothing here is medical advice.

Key Research Focus Areas

• Helix-B erythropoietin fragment identity
• Innate-repair-receptor (EPOR–β-common) signaling
• Preclinical models of peripheral-nerve and inflammatory biology
• Separation of tissue-repair signaling from erythropoietic activity

Important Disclaimer

For research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not medical advice. Handle only in a qualified research setting and in compliance with applicable law.